We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Vir Biotechnology Inc
34 own
11 watching
Current Price
$30.14
$0.23
(0.77%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
4,009.44M
52-Week High
34.9689
52-Week Low
18.05
Average Volume
0.86M
Dividend Yield
--
P/E Ratio
--
Market Capitalization4,009.44M52-Week High34.968952-Week Low18.05Average Volume0.86MDividend Yield--P/E Ratio--What does the Vir Biotechnology Inc do?
Vir Biotechnology Inc is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Infectious diseases are one of the leading causes of death worldwide and cause hundreds of billions of dollars of economic burden each year. Current development pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. VIR-2218, an HBV-targeting siRNA, is in an ongoing Phase 1/2 clinical trial and initial data have demonstrated substantial reduction of hepatitis B virus surface antigen, or HBsAg. Based on initial data, VIR-2218 has been generally well-tolerated.
Read More
How much money does Vir Biotechnology Inc make?
News & Events about Vir Biotechnology Inc.
Ticker Report
9days ago
Vir Biotechnology, Inc. (NASDAQ:VIR Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 36,512 shares of the stock in a transaction dated Monday, January 23rd. The shares were sold at an average price of $28.34, for a total value of $1,034,750.08. Following the sale, the insider ...
Ticker Report
9days ago
Vir Biotechnology, Inc. (NASDAQ:VIR Get Rating) insider Phillip Pang sold 30,000 shares of Vir Biotechnology stock in a transaction dated Tuesday, January 24th. The shares were sold at an average price of $30.00, for a total value of $900,000.00. Following the completion of the transaction, ...
Ticker Report
10days ago
Vir Biotechnology, Inc. (NASDAQ:VIR Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 69,839 shares of the companys stock in a transaction dated Thursday, January 19th. The shares were sold at an average price of $26.56, for a total transaction of $1,854,923.84. Following ...
Globe Newswire
11days ago
Dr. De Backer to assume CEO role on April 3, 2023 Upon his retirement as CEO, Dr. Scangos will transition to an advisory role through June 2, 2023 and will continue providing strategic to Vir as a member of the Board of Directors SAN FRANCISCO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, ...
Zolmax
14days ago
Vir Biotechnology, Inc. (NASDAQ:VIR Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 88,372 shares of the companys stock in a transaction that occurred on Tuesday, January 17th. The shares were sold at an average price of $26.24, for a total value of $2,318,881.28. Following the ...
Frequently Asked Questions
Frequently Asked Questions
What is Vir Biotechnology Inc share price today?
Can Indians buy Vir Biotechnology Inc shares?
How can I buy Vir Biotechnology Inc shares from India?
Can Fractional shares of Vir Biotechnology Inc be purchased?
What are the documents required to start investing in Vir Biotechnology Inc stocks?
What is today’s traded volume of Vir Biotechnology Inc?
What is today’s market capitalisation of Vir Biotechnology Inc?
What is the 52-Week High and Low Range of Vir Biotechnology Inc?
What percentage is Vir Biotechnology Inc down from its 52-Week High?
What percentage is Vir Biotechnology Inc up from its 52-Week Low?
Current Price
$30.14
$0.23
(0.77%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.